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Palliative Gastrostomy in the Setting of Voluminous Ascites
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Diego A. Covarrubias, MD,1 Martin J. Shelly, MB, FFR, RCSI,1 Whitfield Growdon, MD,2
Peter F. Hahn, MD, PhD,1 and Peter R. Mueller, MD1
Abstract
Objective: We report the indications, methods, and complications of percutaneous gastrostomy/gastro-
jejunostomy (G/GJ) in patients with voluminous ascites.
Methods: Following institutional review board approval, 69 patients (14 male, 55 female, mean age 58– 12
years, range 32–89 years) who underwent percutaneous G/GJ with paracentesis were identified from a pro-
spectively acquired database. Electronic medical record data extracted included diagnosis, method of G/GJ
insertion, clinical course, and complications, which were graded by SIR criteriaAU1c . Statistics were performed using
Graphpad Instat.
Results: Sixty-six G and three GJ catheters were placed in 62 patients with malignant and 7 patients with benign
disease; 47 procedures were conducted using fluoroscopy and 22 using computed tomography (CT; 10 patients
had failed fluoroscopy). Sixty-six patients had 1980– 1371 mLAU2c (range, 20–5000 mL) ascites drained (more in
males, p = 0.01) 0.8– 1.6 days (range, 0–5 days) prior to placement. Forty-one patients had significantly less
ascites (1895– 1426 mL; range, 100–5400 mL) drained after G/GJ ( p > 0.0.5). Mean survival after insertion was
43 – 57 days (range, 1–252 days) among 38 patients for whom data were available. Fifty-six patients had a mean
postprocedure hospital stay of 8.6– 8.4 days (range, 0–45 days); 3 were outpatients and 10 patients died in the
hospital. Successful gastropexy was confirmed on subsequent cross-sectional imaging in 22 of 25 patients.
There were 25 tube maintenance issues that included catheter displacement and leakage, one patient experi-
enced hemorrhage, and there were two deaths. All except one patient had satisfactory gastrostomy function.
Conclusion: Effective G/GJ placement is possible in most patients with voluminous ascites provided ascites is
drained and gastrocutaneous fistula formation occurs. Caution is advised; placement is generally for fragile
terminal patients, and fluoroscopy or CT guidance is required.
Introduction
Gastrostomy/Gastrojejunostomy (G/GJ) cathetersare most commonly used to administer enteral feeding
to patients with chronic malnutrition or an inability to eat or
swallow, usually secondary to neurological impairment or
head and neck pathology.1 G/GJ catheters are also inserted
for gastric decompression and palliation for terminal patients,
allowing nasogastric tube removal.2 Insertion may be per-
formed endoscopically, surgically, or radiologically using
fluoroscopic, computed tomography (CT), or ultrasonic guid-
ance. Radiologic or endoscopic gastrostomy placement is
favored over surgery due to higher success rates, reduced
sedation requirements, fewer complications, and lower cost.3
Radiologically guided G tube insertion was first described in
1981.4 The technique has been subsequently modified by use
of gastropexy sutures and the administration of prophylactic
antibiotics in patients with head and neck cancer.5,6 Tech-
nical modifications such as these have expanded the range of
patients in whom G/GJ can be attempted and as a result,
patients who would have previously been considered un-
suitable such as those with ascites are now considered for G/
GJ insertion.7
Although data are sparse, it appears that only a minority of
patients presenting for G/GJ insertion have ascites. Percuta-
neous G/GJ requires development of a well-formed tissue
tract to avoid leaks after insertion. This is usually accom-
plished by gastropexy, forming an adhesion of the anterior
gastric wall to the anterior abdominal wall. In patients with
ascites, however, development of adequate gastropexy re-
quires special considerations, such as repeated periproce-
dural paracentesis. This topic has received little recent
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Table 1. Overview of Patients, Method of Imaging Guidance, and Adequacy of Gastropexy
Variable Overall Male Female P value
Number 69 14 55
Mean age (years) 58.4 – 11.9 59.8 – 16.5 58.0– 10.7 NS
Malignant disease 62 10 52
Benign disease 7 4 3
Fluoroscopy guidance 47 12 35
CT guidance 12 1 11
Failed fluoroscopy then inserted by CT 10 1 9
Number of gastropexy sutures 3.2 – 1.2 (n = 66) 3.8 – 0.6 (n = 14) 3.0 – 1.3 (n = 52) 0.04
Adequate gastropexy on CT 22 of 25 8 of 8 14 of 17
Interval from G/GJ insertion to CT (days) 40.6 – 57.8 39.9 – 62.4 42.1– 51.1 NS
Values presented are means – standard deviation where applicable.
NS, not significant; G/GJ, gastrostomy/gastrojejunostomy; CT, computed tomography.
FIG. 1. G tube placement by fluoroscopy in a 60-year-old male with laryngeal carcinoma and cirrhotic liver disease with
ascites. (A) On-table ultrasound prior to G insertion demonstrates ascites (arrow). Ultrasound guidance was used to perform
paracentesis. (B) Ultrasound following aspiration of 3000 mL of fluid confirms satisfactory paracentesis (arrow). (C) The
stomach was accessed with an 18-gauge needle and an 0.035-inch Amplatz guidewire placed through the center of four
gastropexy sutures (arrow). (D) Satisfactory G placement (arrow) confirmed with contrast injection. Barium noted in the
colon (arrowhead).
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attention in the literature.8 We hypothesized that percutane-
ous G/GJ insertion can be performed safely in patients with
ascites, permitting effective gastric access, for what are often
very ill patients. The purposes of this study were to (1) de-
scribe our methods of G tube insertion in patients with
ascites; (2) report the demographics of the patient population
that requires this procedure; and (3) document the compli-
cations encountered following G/GJ insertion in the presence
of ascites. These were believed to be important for patient
and physician education purposes.
FIG. 2. CT-guided G insertion in a 55-year-old female
with ovarian carcinoma and small bowel obstruction. (A)
Gastric inflation with air following aspiration of 600 mL of
ascites allowed the stomach to approach the anterior ab-
dominal wall (arrow) facilitating safe insertion. (B) G tube
after placement (arrow). There are two gastropexy sutures
present (arrowheads). Although the stomach has deflated, it
is still in contact with the anterior abdominal wall.
FIG. 3. G tube insertion by CT after failed attempt by
fluoroscopy due to large left lobe of liver in a 64-year-old
female with endometrial carcinoma, ascites, and small bo-
wel obstruction. (A) Initial CT image after 800 mL ascites
were aspirated demonstrates a potential intercostal window
(arrow) to the stomach. (B) The stomach was accessed with
a 5F ring needle (arrow) through which an 0.035-inch
Amplatz guidewire was placed into the stomach. (C) A 12F
G (arrow) was placed over the guidewire.
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Methods
Institutional review board approval was obtained from
the regional ethical committee. A retrospective review of
electronic medical and imaging data was performed to
identify patients who had G/GJ insertion and paracentesis
> 300 mL within 5 days of insertion between June 2000 and
June 2010. The following data were retrieved from medical
records: patient demographics, indication for tube insertion,
technique, pre- and postprocedural orders, time to patient
discharge, complications, tube-related complications, and
patient survival.
Oral antiplatelet agents or warfarin were stopped 5 to 7 days
prior to G insertion and subcutaneous anticoagulants were held
on the day of procedure. Preprocedural coagulopathy such as
international normalized ratio >1.6 or platelet count < 50· 103
lL were corrected. The colon was identified at fluoroscopy using
either barium (E-Z EM, Westbury, NY) administered orally the
night before the procedure, or using an on-table enema of either
positive contrast or air. Patients fasted for a minimum of 8 hours
prior to gastrostomy insertion and received conscious sedation or
a general anesthetic depending on clinical need. Ascitic drainage
was performed with ultrasound guidance using local anesthesia
and a 7 French (7F) pigtail catheter inserted over a trochar.
Antibiotic prophylaxis was administered only for patients with
head and neck cancer. G/GJ insertion was performed with pa-
tients placed supine under fluoroscopic or CT guidance. The
stomach was inflated with air using a nasogastric tube or fol-
lowing 5F Kumphe catheter (Cook, Bloomingdale, IN) place-
ment under fluoroscopic guidance through the nose into the
stomach. A safe access window to the stomach was identified,
and in most cases, a section of the anterior gastric wall was fixed
to the anterior abdominal wall using up to four gastropexy su-
tures. G catheters were placed in the stomach between the gas-
tropexy sutures over a wire placed through an 18-gauge hollow
needle. A 14F Dawson-Mueller (Cook, Bloomingdale, IN) G/GJ
catheter with a locking loop was typically used.
Following G/GJ catheter insertion, crushed medications
were permitted through the G/GJ from the time of insertion.
Tube feedings were permitted from 24 hours after insertion.
G/GJ catheters were flushed with 20 mL to 30 mL of normal
saline after feeds or medications were administered to
maintain tubal patency. Gastropexy sutures were removed 2
weeks following gastrostomy insertion.
Values were depicted as means and standard deviations.
Data were compared using Student’s t test. Statistical ana-
lyses were performed using Graphpad Prism version 5.00
(Graphpad Software, San Diego, CA).AU3c A P value < 0.05 was
considered statistically significant.
Results
Sixty-six primary G and three primary GJ insertions were
performed during the study period in 55 females and 14 males
with an average age of 58 years ( bT1Table 1). Almost 90% of
patients had G/GJ insertion performed in the presence of
FIG. 4. G tube insertion by CT after failed attempt by
fluoroscopy due to poor access in a 66-year-old female with
peritoneal carcinomatosis, ascites, and small bowel ob-
struction due to ovarian carcinoma. (A) There was no
window to the stomach at fluoroscopy. The inflated stomach
with nasogastric tube has a subcostal location (arrow). The
costal margin is demarcated by the forceps (arrowhead). (B)
The stomach was accessed with a 5F ring needle (arrow)
through which an 0.035-inch Amplatz guidewire was placed
into the stomach. (C) A 14F G was placed over the guide-
wire between the gastropexy sutures (arrow). A small vol-
ume of subcutaneous emphysema is present.
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ascites due to malignant disease. Insertion was performed for
gastric decompression to relieve small bowel obstruction in
the majority of these cases. Ovarian cancer was the most
common malignancy associated with G/GJ; it was present in
36 of 62 patients with malignancy. Remaining patients with
malignancy had gastrointestinal cancer (9), other gyneco-
logic cancers (7), pancreatic cancer (6), hematologic malig-
nancies (2), lung cancer (1), and breast cancer (1). G/GJ
insertion was performed for feeding in all cases of benign
disease. Cirrhosis combined with neurological impairment
was the most common reason for G/GJ insertion in the
presence of ascites in patients with benign disease (5), one
patient had dialysis-related peritonitis, and one had pancre-
atitis. Fifty-seven G/GJ tubes were placed using fluoroscopic
guidance (F1c Fig. 1) and 22 using CT guidance (
F2c
Fig. 2). Ten
patients failed initial attempted fluoroscopic-guided inser-
tion, and these patients had catheters placed using CT guid-
ance (F3c Figs. 3 and
F4c
4).
Only three G/GJ catheters were placed on an outpatient
basis (T2c Table 2). Ten of the 66 inpatients who had insertion
performed died in the hospital. The average time to discharge
for the remaining 56 patients was 9 days. Data pertaining to
the time of insertion to time of death available for 38 patients
showed an average survival of 43 days following insertion.
Patients had an average of 11 imaging examinations per-
formed within the month prior to G/GJ insertion and six
imaging studies within a month after insertion.
Gastropexy sutures were used in almost all cases (67/69)
with an average of three sutures being used. Evidence of
adequate gastropexy was sought on CT performed after G/GJ
insertion (Table 1). Review of relevant studies in 25 patients
performed on average 41 days after insertion confirmed sat-
isfactory adherence of the stomach to the anterior abdominal
wall in 22 cases. The stomach was remote from the abdom-
inal wall in three patients. In two cases this was due to un-
favorable anatomy: the presence of loculated ascites and
omental disease between the stomach and anterior abdominal
wall in one case ( b F5Fig. 5) and prior gastric bypass that pre-
cluded traction of the stomach anteriorly in the second case
( b F6Fig. 6). These catheters functioned normally, however, and
no complications occurred. One patient was found to have
infected ascites 8 days after G insertion. A microbiology
sample had confirmed absence of infection at the time of G
insertion. When the gastropexy sutures were removed 14
Table 2. Hospital Course
Variable Overall (n = 69) Male (n = 14) Female (n= 55) P value
Inpatient 66 13 53
Number who died in the hospital 10 3 7
Hospital stay (days) 9.2 – 8.8 (n = 56) 12.5 – 11 (n = 10) 8.4 – 8.1 (n = 46) NS
Outpatient 3 1 2
Time from insertion to death (days) 42.5 – 57 (n = 38) 65.2 – 62.8 (n = 4) 42.1 – 58.1 (n = 34) NS
Number of radiologic studies
one month prior to G/GJ
10.9 – 8.5 (n = 69) 14.0 – 5.8 (n = 14) 10.1 – 9.0 (n = 55) NS
Number of radiologic
studies one month after G/GJ
5.9 – 6.1 (n = 62)
( p = 0.0002)
7.1 – 4.8 (n = 12)
( p = 0.003)
5.6 – 6.4 (n = 50)
( p< 0.004)
NS
Values presented are means – standard deviation where applicable.
NS, not significant; G/GJ, gastrostomy/gastrojejunostomy; CT, computed tomography.
FIG. 5. A 41-year-old female with ovarian carcinoma. G
tube was placed under CT guidance 5 days previously after
failed fluoroscopic attempt at insertion. There is displace-
ment of the stomach from the anterior abdominal wall by
ascites (arrow). The ascites was drained and tube injection
showed no leakage.
FIG. 6. A 55-year-old female with gastric cancer and
status post Billroth II subtotal gastrectomy. G was placed
into the afferent loop for decompression. CT 2 months after
insertion shows that the stomach was not pulled up to the
anterior abdominal wall (arrow). The tube functioned nor-
mally.
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days after G tube placement, the stomach retracted from the
anterior abdominal wall and peritoneal contamination oc-
curred (F7c Fig. 7). The patient subsequently succumbed to
sepsis.
Patients had a total of 192 ascitic drainages prior to G/GJ
insertion, averaging 2.9 drainages per patient and 2649 mL
per drainage (T3c Table 3). Ascitic drainages for the purpose of
G/GJ insertion were performed in 66 of 69 patients on av-
erage 0.8 days prior to G/GJ insertion, yielding an average of
almost 2 L of ascites per patient. Patients who did not have
drainage prior to insertion had early drainages after G/GJ
insertion. Forty-one patients had 80 ascitic drainages per-
formed on average 4.8 days after G/GJ insertion and an av-
erage volume of 1937 mL was taken (T4c Table 4). The average
volume of ascites drained on the first drainage after G/GJ
insertion was 1895 mL. Twenty-eight patients did not have
ascites drained after G/GJ insertion. Ten of these patients had
ultrasound after insertion that showed insufficient ascites to
justify drainage.
There were 28 major complications after G/GJ insertion.
Twenty-five patients encountered tube maintenance issues
(SIR grade C complications) after G/GJ insertion. These
consisted of 13 tubes that fell out (F8c Fig. 8), four tubes that
required repositioning within the stomach (F9c Fig. 9), six pa-
tients who experienced leakage, one tube that became
blocked (F10c Fig. 10), and one patient who developed skin ex-
coriation that required direct treatment following leakage.
There was one SIR grade D complication due to hematemesis
from a small ischemic ulcer that occurred in a fold of mucosa
that was trapped by the locking loop of a G tube and required
endoscopy (F11c Fig. 11). Two patients died as a result of SIR
Grade F complications. One, described above, had failed
gastropexy and peritoneal leakage (Fig. 8). The second pa-
tient had small bowel obstruction due to ovarian carcinoma
and died as a result of aspiration that occurred during at-
tempted re-insertion of a G tube that fell out the night after
primary insertion.
Discussion
G/GJ placement in the presence of ascites is a challenging
procedure. Surgical and endoscopic G placement in patients
with ascites is associated with potential greater morbidity and
mortality compared with radiologic insertion.9,10 Ascites
potentially displaces the stomach away from the anterior
abdominal wall, which renders percutaneous gastric puncture
more difficult. Ascites accumulation after G placement can
withdraw a G from the gastric lumen into the peritoneal
cavity with detrimental consequences.11 In addition, G place-
ment in the presence of ascites is associated with an increased
risk of infection and leakage of ascites or gastric contents,
which can cause skin breakdown at the percutaneous punc-
ture site.12,13 Therefore, ascites is currently considered a
relative contraindication to G placement.
The present study is one of the largest studies conducted
assessing G/GJ insertion in the presence of voluminous as-
cites. G/GJ insertion was performed in the same manner to
that of a routine G/GJ except for the additional step of
paracentesis. Paracentesis increases time and resources that
are required for placement of G/GJ; however, this step is
necessary to ensure adequate gastropexy, gastrocutaneous
fistula formation, and prevent G leakage. Paracentesis helped
FIG. 7. A 78-year-old male with diffuse, large B-cell lym-
phoma, portal hypertension, acute renal insufficiency, water-
shed cerebral infarcts, and cirrhosis of unclear etiology. (A)
Uneventful G insertion using fluoroscopic guidance and 3 L
ascites drained. (B) CT demonstrated adequate position of
stomach relative to the abdominal wall 5 days after G insertion
and showed a large volume of ascites. (C) Two ascitic drain-
ages were performed 4 and 8 days after G tube insertion
yielding 4,000 mL ascites on both occasions. Enterococcus coli
was present in the ascites at 8 days. The gastropexy sutures
were removed at 14 days and CT at 16 days shows retraction
of the stomach from the anterior abdominal wall with the
locking loop of the G tube in the peritoneal space (arrow) and
pneumoperitoneum (arrowhead).
6 O’CONNOR ET AL.
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ensure adequate G/GJ function in all but one patient in our
series. In that case, ascitic infection developed after G
placement and inadequate gastrocutaneous fistula formation
occurred after 14 days. We suspect that infection was re-
sponsible for suboptimal gastropexy, which resulted in re-
traction of the stomach from the anterior abdominal wall
when the gastropexy sutures were removed, despite drainage
of considerable volumes of ascites after G placement. This
finding suggests that ascitic fluid drained in the periproce-
dural period should be assessed for infection. Gastropexy
sutures should remain in place for longer in the presence of
infection because these patients are quite ill and probably
require longer than normal for adequate gastropexy to occur.
Results from the present studyindicate that the majority of
patients requiring G placement in the presence of voluminous
ascites suffer from stage IV cancer and chronic small bowel
obstruction. These patients are usually in the late stages of
disease and are quite ill and fragile. Therefore, intervention
should be reserved for patients who do not respond or cope
with nasogastric tube placement and where surgery is not
feasible for relief of obstruction. First-line management for
these patients should entail wide-bore nasogastric tube
placement. G placement, if required in this setting, is for
palliative purposes, to drain the stomach thereby relieving
bowel obstruction and facilitating nasogastric tube removal.
The second patient who died following G insertion did so
after an episode of on-table aspiration during attempted G re-
insertion the day after primary placement. In addition to
fasting for a minimum of 8 hours prior to the procedure, it
may be advantageous that patients with bowel obstruction
have a wide-bore nasogastric tube placed overnight prior to
venting G placement to ensure that the stomach is empty
in advance of supine placement and conscious sedation for
G/GJ placement. Only five patients had benign disease with
GJ/G placed for feeding purposes not possible for prolonged
periods using a feeding tube placed via the nasal passages.
Nonenteral (total parenteral nutrition [TPN]) feeding is an
option for patients with bowel obstruction. TPN administra-
tion in tandem with G tube placement due to bowel ob-
struction (with or without ascites) from gynecologic cancer
has a 5-week survival benefit.14 GJ tubes were placed for one
patient with hepatic encephalopathy, and two patients with
peritoneal carcinomatosis.
There were many tube maintenance issues. These are often
considered separate from complications of G/GJ insertion,
but for the purposes of the present study it was deemed ap-
propriate that these be labeled as major complications. These
issues resulted in additional procedures such as catheter re-
placement, or repositioning, and increased the level of care
that the patients required, therefore meriting consideration as
major complications (SIR grade C). The incidence of major
and minor complications appears to be higher compared with
that of patients without ascites. For example, a review of 254
new Gs and 275 replacement procedures in patients without
ascites had a major complication rate of 1.3% (no deaths) and
a minor complication rate (including tube blockages) of
4.5%.15 These differences are likely a reflection of the clin-
ical condition of the patients requiring G/GJ placement in the
presence of considerable ascites. The mean survival of 38
patients after G/GJ insertion in the present study was only 43
days. The tertiary and quaternary nature of our institution
meant that many patients were discharged to another hospital
Table 3. Ascites Drainages before G/GJ Insertion
Variable Overall (n= 69) Male (n = 14) Female (n = 55) P value
Number of ascitic drainages
prior to G/GJ
2.9 – 3.5 (total = 192) 2.8 – 3.8 (total = 39) 2.9 – 3.8 (total = 153) NS
Ascitic volume drained
prior to G/GJ (mL)
2649– 1815 3468– 1978 2467 – 1731 0.002
Ascitic volume drained
contemporaneous to G/GJ (mL)
1980– 1371 (66 of 69) 2809– 1723 (14 of 14) 1757 – 1182 (52 of 55) 0.01
Time between contemporaneous
drainage and G/GJ (days)
0.8 – 1.6 0.3 – 0.6 1.0 – 1.7 NS
Values presented are means – standard deviation where applicable.
NS, not significant; G/GJ, gastrostomy/gastrojejunostomy.
Table 4. Ascites Drainages after G/GJ Insertion
Variable Overall (n = 69) Male (n = 14) Female (n= 55) P value
Number of ascitic
drainages after G/GJ
1.1 – 0.12 (total = 80)
( p < 0.0001)
1.6 – 1.3 (total= 23) 1.0 – 1.1 (total = 57) 0.04
Ascitic volume drained
after G/GJ (mL)
1937– 1483
( p= 0.002)
1392– 1049 1007– 1639 NS
Ascitic volume drained
contemporaneous to G/GJ (mL)
1895– 1426 (41 of 69)
NS
3000– 1794 (9 of 14) 1624– 1230 (33 of 55) 0.01
Time between contemporaneous
drainage and G/GJ (days)
4.8 – 4.1
( p< 0.0001)
0.3 – 0.6 1.0 – 1.7 NS
Values presented are means – standard deviation where applicable.
NS, not significant; G/GJ, gastrostomy/gastrojejunostomy.
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or nursing or hospice facilities and although lost to follow-up,
were likely to have a short survival after G/GJ placement due
underlying disease. Patient discharge and patient death due to
underlying malignancy probably explain the reduced number
of ascitic drainages and radiologic studies observed after
G/GJ insertion. Once it was established that G/GJ function
was adequate and the gastropexy sutures were removed,
paracentesis was only performed for symptomatic or diag-
nostic purposes.
The present study also highlights the need for radiologists
to be prepared to use CT for G/GJ placement in patients with
voluminous ascites if the majority of patients are to be treated
FIG. 8. G tube reinsertion following dislodgement in a 75-
year-old female with ovarian carcinoma, ascites, and small
bowel obstruction. (A) Contrast injection used to confirm
final G tube (arrow) position at the time of initial insertion.
This tube became dislodged the night after insertion. Co-
lonic barium (arrowhead) is noted. (B) The gastropexy su-
tures were still present (arrow), and so the stomach was
accessed with an 18-gauge needle over which a guidewire
was placed allowing G reinsertion without complication.
FIG. 9. G tube repositioning 12 days after insertion due to
leakage in a 44-year-old woman with gastric obstruction and
ascites due to pancreatic carcinoma. (A) Initial image
demonstrates the tip of the G tube projected over the region
of the distal esophagus (arrow). (B) The G was manipulated
under fluoroscopic guidance and the tip repositioned to lie in
the distal stomach (arrow).
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FIG. 10. G exchange in a 70-year-old female with ovarian
carcinoma, 10 days after gastrostomy insertion. (A) Forceful
contrast injection demonstrated obstruction of the distal
catheter (arrow) and filling of stomach through proximal
side holes. Gastropexy sutures were still present. (B) A
0.035-inch guidewire was placed though the catheter and the
patent side holes. The catheter was exchanged for a new 14F
G tube (arrow).
FIG. 11. Hematemesis in a 50-year-old female following
G insertion for treatment of small bowel obstruction, ascites,
and peritoneal carcinomatosis due to colon carcinoma. (A)
Contrast injection was performed following hematemesis to
confirm adequate G placement. Gastropexy sutures were
still in place (arrowhead). Note the loop (arrow), which is
used to prevent tube displacement from the stomach. (B)
The locking loop was shown to have entrapped a fold of
gastric mucosa on G (arrow) and there was an ischemic
ulcer in the mucosal fold that was believed responsible for
the hematemesis. The G tube was advanced and the mucosa
released. (C) Subsequent CT confirms adequate G (arrow)
placement.
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because there was an 18% failure rate of initial attempts of
fluoroscopic insertion. This was due to unfavorable anatomy
at fluoroscopic insertion such as subcostal gastric position.
The presence of omental, peritoneal, and hepatic metastases
can also render fluoroscopic insertion unsafe. Inspection of
preprocedure CT imaging helped identify 12 of 22 patients
unsuitable for fluoroscopic-guided insertion with a further 10
patients deemed unsuitable on the fluoroscopy table. The vast
majority of patients with voluminous ascites requiring G/GJ
will have cross-sectional imaging available, and we recom-
mend close evaluation of this imaging to plan the procedure.
There are limitations to the present study including the
absence of a control group for comparison and an objective
assessment of quality of life following G/GJ placement,
which would help confirm justification of the procedure over
simply placement of a nasogastric decompression tube. This
is a potential avenue of future research on this topic partic-
ularly because survival was very short and one has to ques-
tion whether patients sufficiently benefit from a procedure
with a high complication rate in their last remaining days (43
days on average). The tertiary nature of our hospital and the
terminal state of so many of our patients resulted in many
patients being lost to follow-up. G/GJ placement in the
presence of voluminous ascites was performed roughly once
every 2 months during the 10-year study period. During this
time period we placed approximately 1600 routine G/GJ
tubes. Therefore G/GJ placement in the presence of volu-
minous ascites is a relatively uncommon procedure and many
different operators were involved in catheter placement.
Eighteen patients had neither paracentesis nor ultrasound
evaluation for ascites performed in our hospital after G/GJ
placement. Many of these patients either died as a result of
their disease or were transferred out of the hospital. Ten pa-
tients did have early postprocedure ultrasound that confirmed
that there was insufficient ascites to merit paracentesis.
Where possible, ultrasound was performed to assess for as-
cites following G/GJ placement. Outside care facilities to
which patients were transferred soon after G/GJ insertion
were instructed to monitor for ascites re-accumulation and to
remove gastropexy sutures after 2 weeks. Compliance with
these instructions cannot be assessed. Other authors advocate
tunneled peritoneal catheter placement to ensure adequate
ascitic drainage and obviate the need for surveillance ultra-
sound.15 We believe that this would add further to the com-
plexity, although this may be useful for patients who are
discharged home.
Conclusion
The findings of this study indicate that G/GJ placement can
be performed safely in the majority of patients with volumi-
nous ascites, but there is a high incidence of complications.
Patients generally require G/GJ placement in this setting for
palliative purposes; these patients are generally very ill and
have terminal disease with short life expectancy. Compared
with routine G/GJ placement, extra precautions are required to
ensure adequate gastropexy and gastrocutaneous fistula for-
mation. Based on the results of this study we recommend re-
view of preprocedure cross-sectional imaging prior to G/GJ
placement in the presence of voluminous ascites, gastric de-
compression if there is small bowel obstruction, drainage of
ascites before and after catheter placement, assessment for
ascitic infection at the time of insertion, and a low threshold for
the use of CT guidance. Justification, effects on quality of life,
and risk-benefit ratio should be assessed in future research.
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